Enerpac Tool
EPAC
Precision Drilling
PDS
Halozyme Therapeutics
HALO
Workday
WDAY
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -273.40%-3.16M | -77.72%683K | -131.14%-765K | 69.83%-668K | -62.36%-2.41M | 136.16%1.82M | 737.21%3.07M | 222.67%2.46M | -1,150.85%-2.21M | 37.63%-1.49M |
Net income from continuing operations | 39.42%-4.43M | 71.88%-1.19M | -202.01%-1.17M | 58.94%-1.09M | 37.37%-982K | -323.75%-7.31M | -141.26%-4.24M | -55.93%1.15M | -105.90%-2.65M | -22.60%-1.57M |
Depreciation and amortization | -2.77%562K | 0.00%141K | 2.16%142K | -6.04%140K | -6.71%139K | -23.95%578K | -18.50%141K | -1.42%139K | -32.58%149K | -33.78%149K |
Other non cash items | 109.88%66K | -31.58%13K | 102.20%18K | 300.00%18K | -88.03%17K | -735.00%-668K | 290.00%19K | -2,462.50%-820K | 70.97%-9K | 2,128.57%142K |
Change In working capital | -111.23%-564K | -70.39%1.2M | -101.37%-22K | 116.67%12K | -222.10%-1.75M | 1,439.20%5.02M | 531.61%4.04M | 729.53%1.6M | -113.26%-72K | 68.97%-543K |
-Change in receivables | -107.67%-289K | -69.60%1.36M | -13,475.00%-535K | 145.80%360K | -1,696.74%-1.47M | 1,115.16%3.77M | 304.81%4.46M | 125.00%4K | -146.39%-786K | 120.18%92K |
-Change in prepaid assets | 58.73%-253K | 12.34%-135K | 11.93%-310K | 175.68%204K | 93.37%-12K | -50.99%-613K | -141.62%-154K | 11.34%-352K | 393.33%74K | 54.06%-181K |
-Change in payables and accrued expense | 460.32%353K | 102.78%219K | -135.44%-140K | 468.83%438K | 68.28%-164K | 123.16%63K | 114.25%108K | 18.98%395K | -87.46%77K | -12.39%-517K |
-Change in other working capital | -120.78%-375K | 34.93%-244K | -38.03%963K | -275.84%-990K | -265.08%-104K | 25,885.71%1.81M | -406.76%-375K | 467.15%1.55M | 141.63%563K | 114.32%63K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -273.40%-3.16M | -77.72%683K | -131.14%-765K | 69.83%-668K | -62.36%-2.41M | 136.16%1.82M | 737.21%3.07M | 222.67%2.46M | -1,150.85%-2.21M | 37.63%-1.49M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 300.06%6.29M | 0.00%1.25M | 12.82%44K | 40.72%-1.73M | 542.95%6.72M | 73.77%-3.14M | 87.97%1.25M | 100.38%39K | -26,400.00%-2.92M | 39.28%-1.52M |
Net PPE purchase and sale | -181.25%-45K | --0 | --0 | ---45K | --0 | -100.20%-16K | --0 | --0 | --0 | ---16K |
Net investment purchase and sale | 302.53%6.34M | 0.00%1.25M | 12.82%44K | 42.26%-1.68M | 547.67%6.72M | 81.92%-3.13M | -0.08%1.25M | 100.21%39K | ---2.92M | ---1.5M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 300.06%6.29M | 0.00%1.25M | 12.82%44K | 40.72%-1.73M | 542.95%6.72M | 73.77%-3.14M | 87.97%1.25M | 100.38%39K | -26,400.00%-2.92M | 39.28%-1.52M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 62.68%-159K | -4,700.00%-184K | 89.68%-13K | -26.92%38K | 0 | 64.02%-426K | 100.37%4K | 30.77%-126K | -42.22%52K | -356K |
Net common stock issuance | 59.09%-207K | -168.13%-244K | 99.21%-1K | -26.92%38K | --0 | 61.43%-506K | 92.68%-91K | 20.25%-126K | -42.22%52K | ---341K |
Proceeds from stock option exercised by employees | -22.92%74K | ---- | ---- | ---- | ---- | -37.66%96K | ---- | ---- | ---- | ---- |
Net other financing activities | -62.50%-26K | -1,300.00%-14K | ---- | ---- | ---- | 38.46%-16K | 50.00%-1K | --0 | --0 | ---15K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 62.68%-159K | -4,700.00%-184K | 89.68%-13K | -26.92%38K | --0 | 64.02%-426K | 100.37%4K | 30.77%-126K | -42.22%52K | ---356K |
Net cash flow | ||||||||||
Beginning cash position | -14.87%10M | 97.48%11.22M | 260.91%11.96M | 70.62%14.32M | -14.87%10M | -60.79%11.75M | -55.10%5.68M | -86.74%3.31M | -66.55%8.39M | -60.79%11.75M |
Current changes in cash | 270.01%2.97M | -59.50%1.75M | -130.97%-734K | 53.56%-2.36M | 228.40%4.31M | 90.41%-1.75M | 575.66%4.32M | 119.23%2.37M | -5,080.61%-5.08M | 31.18%-3.36M |
End cash Position | 29.69%12.97M | 29.69%12.97M | 97.48%11.22M | 260.91%11.96M | 70.62%14.32M | -14.87%10M | -14.87%10M | -55.10%5.68M | -86.74%3.31M | -66.55%8.39M |
Free cash flow | -277.42%-3.21M | -77.72%683K | -131.14%-765K | 67.80%-713K | -60.63%-2.41M | 131.31%1.81M | 387.25%3.07M | 215.03%2.46M | -1,077.66%-2.21M | 36.96%-1.5M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |